SS-31, also known as elamipretide, came out of work on a small family of "SS" (Szeto-Schiller) peptides designed to concentrate at mitochondria. It emerged from research into aromatic-cationic sequences that could target a specific inner-membrane environment, and it became the best-known member of that series.
The aromatic-cationic idea
The founding insight was that an alternating pattern of aromatic and positively charged residues could steer a small peptide toward mitochondrial membranes without relying on a dedicated transporter. This unusual property — selective accumulation driven by sequence design alone — is the basis of its mechanism of action and set the SS peptides apart from earlier compounds.
A designed, not derived, peptide
Unlike fragments carved from larger proteins, SS-31 was purpose-built from the ground up, incorporating non-natural residues chosen for targeting and stability, as described in its structure and synthesis. This makes it a clear example of rational peptide engineering rather than natural-product discovery.
The Szeto-Schiller series
The broader SS family explored variations on the aromatic-cationic theme, with SS-31 becoming the lead research compound because of its favorable combination of targeting and stability. Its naming reflects the investigators who characterized the series.
Its place among mitochondrial tools
SS-31 became a reference compound for mitochondria-targeted peptide research, discussed alongside other mitochondria-associated molecules like MOTS-c, though the two reach and act on mitochondria in different ways. Background is in the SS-31 research overview.
Why the platform was unusual
Earlier mitochondrial targeting strategies often relied on lipophilic cations or larger targeting sequences. The Szeto-Schiller work showed that a very short, water-compatible peptide could display organelle preference through a repeated aromatic-cationic motif. That observation created a platform rather than a single isolated compound: sequence variants could be used to ask which residues controlled membrane association, redox-related behavior, and stability. SS-31 became prominent because it combined mitochondrial localization with a chemically tractable tetrapeptide format. Its history therefore links basic studies of sequence-dependent partitioning with the broader development of organelle-directed molecular probes. The platform also helped shift attention from simple organelle accumulation to molecular interactions within mitochondrial membranes. As cardiolipin became central to the working model, SS-31 offered a way to connect sequence design with membrane biophysics and measurable bioenergetic endpoints. That progression explains why the compound remains useful in both chemistry-led and cell-biology research.
Product page: SS-31 research vials.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.